Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Child with a bandaged wrist © SHUTTERSTOCK

Torus fractures (also called buckle fractures) of the wrist are the most common type of broken bone in children affecting about 60K alone a year in the UK. It is the mildest form of broken bone in which the distal radius bone crushes (or buckles), instead of breaking.

National and international guidelines and practice for treatment varies. Doctors prescribe either the use of a plaster cast or hard splint to immobilise the wrist, or offer a bandage, but no 'standard' treatment has been agreed.

Daniel Perry, Associate Professor, Orthopaedics and Trauma Surgery at NDORMS, University of Oxford explained: "It is a common belief amongst both families and clinicians that a fracture needs plaster cast immobilisation to ensure adequate healing. However, evidence suggested that a bandage or no treatment was just as effective. We started the FORCE trial because it was not clear how much difference each treatment made to a patient's recovery."

The study, published in The Lancet, recruited 965 children aged 4-15 years with a radiologically confirmed torus fracture of the distal radius. They were randomised equally to receive either a bandage and no planned follow up, or a rigid splint and the usual outpatient follow up.

Patients recorded their level of pain, recovery using the arm, quality of life, complications encountered, and school absences for a period of 6 weeks after the treatment.

The study found equivalence in the two outcomes. A bandage with no planned follow up is equally as good as restricting movement with a hard splint and outpatient follow up.

Daniel said: "FORCE highlights the over-treatment that happens in many parts of practice. As doctors, we've always been taught to splint all broken bones – though in reality we know that many children with this injury present to hospital after several days as their parents considered it a wrist sprain, and indeed many almost certainly never come! As clinicians, we need to shift our mindset to consider buckle fractures as a wrist sprain and treat it with love and reassurance. With more research, perhaps we can move to a situation where we don't even x-ray many wrist injuries in children."

The FORCE Study was funded by National Institute for Health Research, Health Technology Assessment (HTA) Programme (ref: 17/23/02). The information contained in this website is for general information about the FORCE study and provided by the University of Oxford (Oxford Trauma). The views expressed are those of the study authors and are not intended to be representative of the views of the funder, sponsor or other participating organisations.

Learn more at the FORCE study website

Similar stories

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Empowering data science for single-cell analysis in Zimbabwe

An innovative computational biology training module was launched in November 2022 at the African Institute of Biomedical Science and Technology (AiBST) in Harare, Zimbabwe, where MSc students were trained in single-cell RNA sequencing data analysis.

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.